Rockefeller Capital Management L.P. Purchases 11,503 Shares of The Cooper Companies, Inc. $COO

Rockefeller Capital Management L.P. lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 156.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,855 shares of the medical device company’s stock after purchasing an additional 11,503 shares during the period. Rockefeller Capital Management L.P.’s holdings in Cooper Companies were worth $1,545,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP boosted its position in Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. Generation Investment Management LLP bought a new position in shares of Cooper Companies during the fourth quarter valued at $233,539,000. Diamond Hill Capital Management Inc. raised its stake in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after acquiring an additional 2,720,594 shares during the last quarter. JANA Partners Management LP acquired a new position in shares of Cooper Companies during the third quarter worth $166,917,000. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of a number of recent research reports. Barclays increased their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Stifel Nicolaus decreased their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Finally, Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, Cooper Companies has an average rating of “Hold” and an average price target of $81.31.

Cooper Companies Price Performance

COO stock opened at $71.71 on Wednesday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a market cap of $13.99 billion, a price-to-earnings ratio of 60.77, a PEG ratio of 1.87 and a beta of 0.87. The company’s fifty day simple moving average is $64.18 and its 200 day simple moving average is $73.50. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the business posted $0.96 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.